Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa J Christopher

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of Labelled Compounds & Radiopharmaceuticals|November 29, 2013
The synthesis of a carbon-14 labeled pegylated Adnectin™ for placental transfer studies in guinea pigsBrad D Maxwell, Kai Cao, Samuel Bonacorsi, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 22, 2012
Liquid chromatography and tandem mass spectrometry method for the quantitative determination of saxagliptin and its major pharmacologically active 5-monohydroxy metabolite in human plasma: method validation and overcoming specific and non-specific binding at low concentrationsXiaohui Sophia Xu, Roger Demers, Huidong Gu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 2011
Metabolism and disposition of [14C]brivanib alaninate after oral administration to rats, monkeys, and humansJiachang Gong, Jinping Gan, Janet Caceres-Cortes, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 24, 2015
Characterization of Organic Anion Transporter 2 (SLC22A7): A Highly Efficient Transporter for Creatinine and Species-Dependent Renal Tubular ExpressionHong Shen, Tongtong Liu, Bridget L Morse, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 3, 2009
Pharmacokinetics of the dipeptidyl peptidase 4 inhibitor saxagliptin in rats, dogs, and monkeys and clinical projectionsAberra Fura, Ashish Khanna, Viral Vyas, et al.
Journal of Medicinal Chemistry|September 28, 2023
The Importance of Tracking "Missing" Metabolites: How and Why?Shuai Wang, T Eric Ballard, Lisa J Christopher, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 30, 2010
Metabolism and disposition of [14C]BMS-690514, an ErbB/vascular endothelial growth factor receptor inhibitor, after oral administration to humansLisa J Christopher, Haizheng Hong, Blisse J Vakkalagadda, et al.
Bioanalysis|September 5, 2012
Overcoming bioanalytical challenges in an Onglyza(®) intravenous [(14)C]microdose absolute bioavailability study with accelerator MSXiaohui Sophia Xu, Stephen R Dueker, Lisa J Christopher, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 13, 2023
Metabolomic Profiling and Drug Interaction Characterization Reveal Riboflavin As a Breast Cancer Resistance Protein-Specific Endogenous Biomarker That Demonstrates Prediction of Transporter Activity In VivoYueping Zhang, Petia A Shipkova, Bethanne M Warrack, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 19, 2008
Biotransformation of [14C]dasatinib: in vitro studies in rat, monkey, and human and disposition after administration to rats and monkeysLisa J Christopher, Donghui Cui, Wenying Li, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Labelled Compounds & Radiopharmaceuticals|November 29, 2013
The synthesis of a carbon-14 labeled pegylated Adnectin™ for placental transfer studies in guinea pigsBrad D Maxwell, Kai Cao, Samuel Bonacorsi, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 22, 2012
Liquid chromatography and tandem mass spectrometry method for the quantitative determination of saxagliptin and its major pharmacologically active 5-monohydroxy metabolite in human plasma: method validation and overcoming specific and non-specific binding at low concentrationsXiaohui Sophia Xu, Roger Demers, Huidong Gu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 2011
Metabolism and disposition of [14C]brivanib alaninate after oral administration to rats, monkeys, and humansJiachang Gong, Jinping Gan, Janet Caceres-Cortes, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 24, 2015
Characterization of Organic Anion Transporter 2 (SLC22A7): A Highly Efficient Transporter for Creatinine and Species-Dependent Renal Tubular ExpressionHong Shen, Tongtong Liu, Bridget L Morse, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 3, 2009
Pharmacokinetics of the dipeptidyl peptidase 4 inhibitor saxagliptin in rats, dogs, and monkeys and clinical projectionsAberra Fura, Ashish Khanna, Viral Vyas, et al.
Journal of Medicinal Chemistry|September 28, 2023
The Importance of Tracking "Missing" Metabolites: How and Why?Shuai Wang, T Eric Ballard, Lisa J Christopher, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 30, 2010
Metabolism and disposition of [14C]BMS-690514, an ErbB/vascular endothelial growth factor receptor inhibitor, after oral administration to humansLisa J Christopher, Haizheng Hong, Blisse J Vakkalagadda, et al.
Bioanalysis|September 5, 2012
Overcoming bioanalytical challenges in an Onglyza(®) intravenous [(14)C]microdose absolute bioavailability study with accelerator MSXiaohui Sophia Xu, Stephen R Dueker, Lisa J Christopher, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 13, 2023
Metabolomic Profiling and Drug Interaction Characterization Reveal Riboflavin As a Breast Cancer Resistance Protein-Specific Endogenous Biomarker That Demonstrates Prediction of Transporter Activity In VivoYueping Zhang, Petia A Shipkova, Bethanne M Warrack, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 19, 2008
Biotransformation of [14C]dasatinib: in vitro studies in rat, monkey, and human and disposition after administration to rats and monkeysLisa J Christopher, Donghui Cui, Wenying Li, et al.
Pageof 4